- Home
- TRMD vs CLDX Comparison
TRMD vs CLDX Comparison
Compare TRMD & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TRMD | CLDX |
|---|---|---|
| Founded | 1889 | N/A |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 1.9B |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | TRMD | CLDX |
|---|---|---|
| Price | $20.46 | $27.10 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 10 |
| Target Price | $23.00 | ★ $43.80 |
| AVG Volume (30 Days) | 515.6K | ★ 775.5K |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | ★ 9.85% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.76 | N/A |
| Revenue | ★ $1,292,300,000.00 | $2,599,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $19.70 |
| P/E Ratio | $7.57 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.60 | $14.40 |
| 52 Week High | $23.67 | $30.50 |
Technical Indicators
Market Signals| Indicator | TRMD | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 36.53 | 50.84 |
| Support Level | $20.35 | $27.51 |
| Resistance Level | $20.91 | $28.79 |
| Average True Range (ATR) | 0.38 | 1.30 |
| MACD | -0.13 | -0.05 |
| Stochastic Oscillator | 7.34 | 29.73 |
Price Performance
Historical ComparisonAbout TRMD TORM plc
TORM PLC operates as a shipping company. The company owns and operates product tankers. It is engaged in the transportation of refined oil products The company transports clean petroleum products including gasoline, jet fuel, naphtha, and diesel oil, as well as other clean products. Its segments include the Tanker segment, and Marine Engineering segment. The company derives maximum revenue from Tanker segment.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.